List of works - Tony W Ho

A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine

scientific article

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

scientific article

Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults

scientific article

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

scientific article

Antimigraine efficacy of telcagepant based on patient's historical triptan response

scientific article

Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China

article

CGRP and its receptors provide new insights into migraine pathophysiology

scientific article published on 07 September 2010

CGRP receptor antagonism and migraine

scientific article published on April 2010

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

scientific article published on August 1998

CampylobacterSpecies and Guillain-Barré Syndrome ⬇️

scientific article published on July 1, 1998

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

scientific article published in April 2002

Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial

scientific article published on 02 May 2010

Differential Distribution of HLA-DQ /DR Epitopes in the Two Forms of Guillain-Barre Syndrome, Acute Motor Axonal Neuropathy and Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Identification of DQ Epitopes Associated with Susceptibility to an

scientific article published on 01 March 2003

Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome

scientific article published in December 1997

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

scientific article

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

scientific article

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders

scientific article

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design

scientific article published on 18 June 2012

Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies

scientific article published on 14 November 2008

Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan

scientific article published in October 2009

Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine: A Response ⬇️

scientific article published on April 1, 2011

Expanding access to triptans: assessment of clinical outcome

scientific article published on 8 October 2009

Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers.

scientific article published on January 2003

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies ⬇️

scientific article published on June 1, 1995

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

scientific article

Human autoimmune neuropathies

scientific article published on January 1998

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

scientific article published on 01 May 1996

Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis

scientific article

Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain

scientific article published on 23 December 2010

Improving patient selection for clinical acute stroke trials

scientific article published on 15 February 2006

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)

scientific article

Intermediate clinical endpoints: a bridge between progression-free survival and overall survival in ovarian cancer trials

scientific article

Is there an inherent limit to acute migraine treatment efficacy?

scientific article published on 10 October 2009

Key concepts of migraine postdrome: a qualitative study to develop a post-migraine questionnaire

scientific article published on January 2011

Long-Term Open-Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs

article

Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial

scientific article published on 10 November 2010

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease

scientific article published on 15 April 2013

Migraine in the triptan era: progresses achieved, lessons learned and future developments

scientific article published on June 2009

Molecular mimicry in Guillain-Barré syndrome.

scientific article published in June 1998

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

scientific article published on March 1997

Outcomes and endpoints in cancer trials: bridging the divide

scientific article

Pathology of the motor-sensory axonal Guillain-Barré syndrome

scientific article published on 01 January 1996

Patterns of recovery in the Guillain-Barre syndromes

scientific article published on 01 March 1997

Physiologic-pathologic correlation in Guillain-Barre syndrome in children

scientific article published on 01 January 2000

Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant

scientific article

Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension

article

Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine

scientific article published in April 2011

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

scientific article

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention

scientific article published on 8 August 2014

Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine

scholarly article by Tony W Ho et al published 29 April 2015 in Cephalalgia

Randomized, controlled trial of telcagepant for the acute treatment of migraine

scientific article published on September 2009

Randomized, controlled trial of telcagepant over four migraine attacks

scientific article

Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases

Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.

scientific article published in May 2009

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis

scientific article

Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection

scientific article published on 7 November 2005

Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan

scientific article

TGFbeta trophic factors differentially modulate motor axon outgrowth and protection from excitotoxicity

scientific article

Ten years of rizatriptan: from development to clinical science and future directions

scientific article published on February 2009

The Guillain-Barré syndrome at 75: TheCampylobacterconnection

article

The clinical correlates of high-titer IgG anti-GM1 antibodies

scientific article published on 01 February 1994

Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.

scientific article

Triptan persistency among newly initiated users in a pharmacy claims database

scientific article published on 11 October 2010

List of works by Tony W Ho

A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

Antimigraine efficacy of telcagepant based on patient's historical triptan response

Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China

CGRP and its receptors provide new insights into migraine pathophysiology

CGRP receptor antagonism and migraine

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

CampylobacterSpecies and Guillain-Barré Syndrome ⬇️

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial

Differential Distribution of HLA-DQ /DR Epitopes in the Two Forms of Guillain-Barre Syndrome, Acute Motor Axonal Neuropathy and Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Identification of DQ Epitopes Associated with Susceptibility to an

Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design

Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies

Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan

Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine: A Response ⬇️

Expanding access to triptans: assessment of clinical outcome

Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers.

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies ⬇️

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

Human autoimmune neuropathies

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis

Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain

Improving patient selection for clinical acute stroke trials

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)

Intermediate clinical endpoints: a bridge between progression-free survival and overall survival in ovarian cancer trials

Is there an inherent limit to acute migraine treatment efficacy?

Key concepts of migraine postdrome: a qualitative study to develop a post-migraine questionnaire

Long-Term Open-Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs

Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease

Migraine in the triptan era: progresses achieved, lessons learned and future developments

Molecular mimicry in Guillain-Barré syndrome.

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

Outcomes and endpoints in cancer trials: bridging the divide

Pathology of the motor-sensory axonal Guillain-Barré syndrome

Patterns of recovery in the Guillain-Barre syndromes

Physiologic-pathologic correlation in Guillain-Barre syndrome in children

Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant

Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension

Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention

Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine

Randomized, controlled trial of telcagepant for the acute treatment of migraine

Randomized, controlled trial of telcagepant over four migraine attacks

Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases

Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis

Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection

Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan

TGFbeta trophic factors differentially modulate motor axon outgrowth and protection from excitotoxicity

Ten years of rizatriptan: from development to clinical science and future directions

The Guillain-Barré syndrome at 75: TheCampylobacterconnection

The clinical correlates of high-titer IgG anti-GM1 antibodies

Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.

Triptan persistency among newly initiated users in a pharmacy claims database